JACQUELINE BOUCHER-STEWART: Open Payments
NPI 1225329360 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 19 payments from 7 companies in 2025. Trend: 2023 $136 · 2024 $230 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $95 |
| Lilly USA, LLC | 4 | $63 |
| PFIZER INC. | 4 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Seqirus USA Inc | 1 | $16 |
Products named: MOUNJARO, VRAYLAR, UBRELVY, TRUMENBA, XIFAXAN, FARXIGA, BEXSERO, Fluad.
Industry payments across OH — which companies pay providers there.
